Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence. (6th November 2014) - Greene, Julia; Schneble, Erika; Berry, John; Trappey, Alfred; Vreeland, Timothy; Clifton, Guy; McGuire, William; Maxwell, George; Ponniah, Sathibalan; Peoples, George